‘Breakthrough’ Leukemia Drug Also Portends ‘Quantum Leap’ In Cost
(By Liz Szabo for Kaiser Health News) When doctors talk about a new leukemia drug from Novartis, they ooze enthusiasm,
Read More
Part D/Prescription Drugs
Dying At Home In An Opioid Crisis: Hospices Grapple With Stolen Meds
(By Melissa Bailey for Kaiser Health News) Nothing seemed to help the patient — and hospice staff didn’t know why.
Read MoreFood and Drug Administration Reauthorization Act of 2017
President Trump quietly signed into law the Food and Drug Administration Reauthorization Act of 2017 which extends the user fee
Read MoreExpress Scripts to limit opioids for first time users: 4 things to know
(By Brian Zimmerman for Becker’s Hospital Review) Express Scripts — the nation’s largest pharmacy benefit manager — will begin limiting
Read MoreOpioid Crisis Strains Foster Care System; Programs Aim To Keep Kids With Mom
(By Shefali Luthra for Kaiser Health News) After Raven Mosser gave birth six years ago, she woke up to a
Read MoreStigma Keeps Some Doctors From Treating Drug Addiction
(By Stephanie Daniel – The Pulse- Published by Side Effects) Internal medicine physician Chinazo Cunningham runs a family health center
Read MoreImportant Decisions Involved in Signing Up for Medicare
If you are approaching your 65th birthday, you have an important decision to make – signing up for Medicare. If
Read MoreCongress Launching Probe into MS Drug Pricing
U.S. House Committee on Oversight and Government Reform is launching an investigation into why prices for Multiple Sclerosis (MS) treatments
Read MoreMylan Agrees to Pay $465 million in a Settlement for EpiPen Overcharges
Mylan, the makers of EpiPen, and federal investigators finalized a $465 million settlement of charge the drugmaker avoided paying state
Read MoreA Supreme Court pharma case deals consumers a big loss
(By Michael Burg for STAT) In the war being waged by large corporations against individual rights — and, yes, it
Read More